These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 24566573)

  • 1. Vitiligo, NB-UVB and tacrolimus: our experience in Naples.
    Baldo A; Lodi G; Di Caterino P; Monfrecola G
    G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
    Majid I
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D; Cassano N; Vena GA
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
    Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
    Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study.
    Nordal EJ; Guleng GE; Rönnevig JR
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1440-3. PubMed ID: 21466589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
    Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
    Kullavanijaya P; Lim HW
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo.
    Lo YH; Cheng GS; Huang CC; Chang WY; Wu CS
    J Dermatol; 2010 Feb; 37(2):125-9. PubMed ID: 20175845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
    Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S
    Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series.
    Tanghetti EA
    Cutis; 2003 Feb; 71(2):158-62. PubMed ID: 12635898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
    Khullar G; Kanwar AJ; Singh S; Parsad D
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
    Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
    Hartmann A; Bröcker EB; Hamm H
    Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.